Method for determining genetic predisposition for seronegative spondyloarthropathies and products useful therefor
US5753442A · kind A · utility
0Cited by
1References
86Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 1, 1995 |
| Grant date | May 19, 1998 |
| Priority date | — |
| Expiry date | Sep 1, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/81
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
In accordance with the present invention, there are provided isolated nucleic acids useful in diagnostic methods and kits for detecting a genetic predisposition for seronegative spondyloarthropathies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.